<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34707167</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>10</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>IFNL4 genetic variant can predispose to COVID-19.</ArticleTitle><Pagination><MedlinePgn>21185</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-00747-z</ELocationID><Abstract><AbstractText>Interferon lambda 4 (IFNλ4) has shown antiviral activity against RNA viruses, including some coronaviruses. Besides, genetic variants of IFNL4 can be predictive of the clearance of RNA viruses. However, little is known about the effect of these genetic variants on SARS-CoV-2 infection. In this study, we investigated whether there was a relationship of the rs12979860 polymorphism of IFNL4 with COVID-19. We found that the T allele of rs12979860 was overexpressed in COVID-19 patients with regard to the general population without this disease (36.16% vs. 26.40%, p = 6.4 × 10<sup>-4</sup>; OR 0.633 C vs T; 95% CI 0.487, 0.824), suggesting that this allele could be a risk factor for COVID-19. Accordingly, the CC genotype was significantly lower in COVID-19 patients compared to controls (37.85% vs. 55.51%, p = 8 × 10<sup>-5</sup>; OR 0.488; 95% CI 0.342, 0.698). These results were not affected by sex, age, and disease severity in patients with COVID-19. Our findings suggest that, like other infectious diseases caused by RNA viruses, genetic variants of IFNL4 can predispose to COVID-19. Confirmation of our results may contribute to better understanding the mechanisms of this disease.</AbstractText><CopyrightInformation>© 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Saponi-Cortes</LastName><ForeName>Jose Maria R</ForeName><Initials>JMR</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Complejo Hospitalario Universitario de Caceres, Caceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rivas</LastName><ForeName>Maria Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Unidad de Investigacion, Complejo Hospitalario Universitario de Caceres, Avenida Pablo Naranjo s/n, 10003, Caceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calle-Alonso</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departamento de Didactica de Matematicas, Universidad de Extremadura, Caceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Juan F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Complejo Hospitalario Universitario de Caceres, Caceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Complejo Hospitalario Universitario de Caceres, Caceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Complejo Hospitalario Universitario de Caceres, Caceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamorano</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Investigacion, Complejo Hospitalario Universitario de Caceres, Avenida Pablo Naranjo s/n, 10003, Caceres, Spain. jose.zamorano@salud-juntaex.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PTA2017-13904-I</GrantID><Agency>Ministerio de Ciencia e Innovación</Agency><Country/></Grant><Grant><GrantID>MTM2017-86875-C3-2</GrantID><Agency>Ministerio de Ciencia e Innovación</Agency><Country/></Grant><Grant><GrantID>GR18105</GrantID><Agency>Junta de Extremadura</Agency><Country/></Grant><Grant><GrantID>GR18108</GrantID><Agency>Junta de Extremadura</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579163">IFNL4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>04</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34707167</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-00747-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-00747-z</ArticleId><ArticleId IdType="pmc">PMC8551167</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2009 Sep 17;461(7262):399-401</Citation><ArticleIdList><ArticleId IdType="pubmed">19684573</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Cell Infect Microbiol. 2019 Oct 04;9:340</Citation><ArticleIdList><ArticleId IdType="pubmed">31637221</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2020 Jun 16;52(6):910-941</Citation><ArticleIdList><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Oct 29;383(18):1757-1766</Citation><ArticleIdList><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Feb;45(2):164-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23291588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2020 Sep 9;28(3):455-464.e2</Citation><ArticleIdList><ArticleId IdType="pubmed">32707096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Oct 8;461(7265):798-801</Citation><ArticleIdList><ArticleId IdType="pubmed">19759533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Nov;587(7834):374-376</Citation><ArticleIdList><ArticleId IdType="pubmed">33139913</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2013 Nov 27;32(23):3055-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24169568</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Med. 2020 Oct 15;9(10):</Citation><ArticleIdList><ArticleId IdType="pubmed">33076493</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jan 17;9(1):e85899</Citation><ArticleIdList><ArticleId IdType="pubmed">24465773</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Jun 23;323(24):2466-2467</Citation><ArticleIdList><ArticleId IdType="pubmed">32391864</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2021 Feb 11;384(6):497-511</Citation><ArticleIdList><ArticleId IdType="pubmed">33264556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2020 Jul 7;32(1):107863</Citation><ArticleIdList><ArticleId IdType="pubmed">32610043</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 25;382(26):2534-2543</Citation><ArticleIdList><ArticleId IdType="pubmed">32459916</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Mar;8(3):e1000420</Citation><ArticleIdList><ArticleId IdType="pubmed">21423587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation><ArticleIdList><ArticleId IdType="pubmed">32401715</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>